Nurse Practitioner, Family · Duarte, CA
NPI
1811582539
Since 2021
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1500 Duarte Rd
Duarte, CA, 91010
Phone (626) 256-4673
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
278 services
Medicare patients, 2024
63
Average age 70
Drug cost, 2024
$3.0M
2,218 prescriptions
Company payments, 2025
$328
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rachel G Davidians was code 99214 (office e&m - established), 179 times for 53 patients. In total Rachel G Davidians billed 278 services in 7 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 179 | 53 | $67.33 | $12K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 36 | 13 | $12.09 | $435 |
By year: 2022 $8,507 for 121 services; 2023 $18K for 235 services; 2024 $19K for 278 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rachel G Davidians prescribed most often to Medicare patients was Acyclovir, with 237 prescriptions and refills. In total Rachel G Davidians wrote 2,218 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 237 | 347 | 46 | $2,333 |
| Pantoprazole Sodium Generic | 151 | 229 | 35 | $917 |
| Amlodipine Besylate Generic | 89 | 145 | 17 | $209 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 82 | 105 | 21 | $353 |
| Ursodiol Generic | 79 | 95 | 17 | $5,213 |
| Jakafi Ruxolitinib Phosphate | 79 | 79 | 15 | $1.2M |
| Atovaquone Generic | 79 | 81 | 15 | $30K |
| Posaconazole Generic | 76 | 77 | 20 | $89K |
| Allopurinol Generic | 53 | 79 | Under 11 | $295 |
| Cresemba Isavuconazonium Sulfate | 48 | 50 | Under 11 | $300K |
| Metoprolol Tartrate Generic | 45 | 74 | Under 11 | $147 |
| Gabapentin Generic | 41 | 42 | 11 | $749 |
| Alendronate Sodium Generic | 38 | 75 | Under 11 | $82.9 |
| Tacrolimus Generic | 38 | 57 | 16 | $2,894 |
| Rosuvastatin Calcium Generic | 36 | 68 | Under 11 | $390 |
Brand drugs: 382 claims; generic drugs: 1,822 claims; opioid claims: 30.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rachel G Davidians $328 ($328 in general payments such as food, travel and fees) from 6 companies. The largest payer was Stemline Therapeutics Inc. with $197.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.